PSA doubling time of prostate carcinoma managed with watchful observation alone
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (3) , 615-620
- https://doi.org/10.1016/s0360-3016(01)01511-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Observations of prostate specific antigen doubling time in Japanese patients with nonmetastatic prostate carcinomaCancer, 1999
- EVALUATION OF CHANGES IN PROSTATE SPECIFIC ANTIGEN IN CLINICALLY LOCALIZED PROSTATE CANCER MANAGED WITHOUT INITIAL THERAPYJournal of Urology, 1998
- Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behaviorInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate CancerJournal of Urology, 1994
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980
- Etiology, epidemiology, and pathology of prostatic cancerCancer, 1973